Andres Ceballos-Garzon
Overview
Explore the profile of Andres Ceballos-Garzon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ceballos-Garzon A, Comtet-Marre S, Peyret P
Virus Res
. 2023 Dec;
340:199293.
PMID: 38101578
Although next-generation sequencing technologies are advancing rapidly, many research topics often require selective sequencing of genomic regions of interest. In addition, sequencing low-titre viruses is challenging, especially for coronaviruses, which...
2.
Rodriguez M, Gomez A, Ceballos-Garzon A
Antibiotics (Basel)
. 2023 Nov;
12(11).
PMID: 37998777
is a very prevalent etiologic agent of bovine mastitis, and antibiotic resistance contributes to the successful colonization and dissemination of these bacteria in different environments and hosts on dairy farms....
3.
Rodriguez M, Gomez A, Marcela Parra-Giraldo C, Ceballos-Garzon A
Microb Ecol
. 2023 May;
86(4):2320-2329.
PMID: 37222805
Staphylococcus aureus is one of the most prevalent pathogens causing bovine mastitis in the world, in part because of its ease of adaptation to various hosts and the environment. This...
4.
Alvarez-Moreno C, Morales-Lopez S, Rodriguez G, Rodriguez J, Robert E, Picot C, et al.
J Fungi (Basel)
. 2023 Apr;
9(4).
PMID: 37108885
has become a major health threat due to its transmissibility, multidrug resistance and severe outcomes. In a case-control design, 74 hospitalised patients with candidemia were enrolled. In total, 22 cases...
5.
Ceballos-Garzon A, Penuela A, Valderrama-Beltran S, Vargas-Casanova Y, Ariza B, Parra-Giraldo C
Front Cell Infect Microbiol
. 2023 Apr;
13:1136217.
PMID: 37026059
Methods: Over a four-year period, 123 Candida bloodstream isolates were collected at a quaternary care hospital. The isolates were identified by MALDI-TOF MS and their fluconazole (FLC) susceptibility patterns were...
6.
Aguirre-Guataqui K, Marquez-Torres M, Pineda-Castaneda H, Vargas-Casanova Y, Ceballos-Garzon A, Rivera-Monroy Z, et al.
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36358216
Antimicrobial peptides (AMPs) are considered to be a valuable source for the identification and/or design of promising candidates for the development of antifungal treatments, since they have advantages such as...
7.
Ceballos-Garzon A, Munoz A, Plata J, Sanchez-Quitian Z, Ramos-Vivas J
Pathog Dis
. 2022 Oct;
80(1).
PMID: 36255384
Phages are viruses that infect bacteria, relying on their genetic machinery to replicate. To survive the constant attack of phages, bacteria have developed diverse defense strategies to act against them....
8.
Bravo-Chaucanes C, Vargas-Casanova Y, Chitiva-Chitiva L, Ceballos-Garzon A, Modesti-Costa G, Marcela Parra-Giraldo C
J Fungi (Basel)
. 2022 Aug;
8(8).
PMID: 36012773
Due to the increased incidence of fungal infections and the emergence of antifungal resistance mainly by species, the need for safe and effective novel therapies is imperative. Consequently, plants and...
9.
Libisch B, Picot C, Ceballos-Garzon A, Moravkova M, Klimesova M, Telkes G, et al.
Microorganisms
. 2022 May;
10(5).
PMID: 35630382
microalgae were only recognized as pathogens of both humans and animals in the 1960s; however, since then, these microbes have been drawing increasing interest in both human and veterinary medicine....
10.
Ceballos-Garzon A, Roman E, Pla J, Pagniez F, Amado D, Almeciga-Diaz C, et al.
PLoS One
. 2022 Mar;
17(3):e0265777.
PMID: 35303047
Invasive fungal infections, which kill more than 1.6 million patients each year worldwide, are difficult to treat due to the limited number of antifungal drugs (azoles, echinocandins, and polyenes) and...